申请人:Arvanitis G. Argyrios
公开号:US20070149506A1
公开(公告)日:2007-06-28
The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
本发明提供了可调节Janus激酶活性并且在治疗与Janus激酶活性相关的疾病方面有用的化合物,包括但不限于免疫相关疾病、皮肤疾病、髓细胞增生性疾病、癌症和其他疾病。